Abstract
Background/Aims: The enterohepatic circulation of bile acids is related to normal inter-digestive gastrointestinal motility, with the gut peptide motilin also being involved. This study aimed to investigate the effect of intraduodenal artificial bile infusion on antroduodenal and gallbladder motility so as to further elucidate the controlling factors. Methods: Twelve fasting, healthy male volunteers received artificial bile (80 mol% bile acids; 15 mol% phospholipids; 5 mol% cholesterol) or placebo (saline) intraduodenally for 10 min starting 30 min after the end of phase III, according to a double-blind, randomised, cross-over design. Antroduodenal motility, gallbladder volumes, and plasma motilin levels were measured. All values are means ± SEM. Results: The interval between infusion and the subsequent phase III, as well as the origin of this phase III were not significantly different between bile and saline. Antral pressure waves were significantly more frequent during and immediately after bile infusion compared with saline infusion (p < 0.05). The duration of phase I following infusion was significantly longer after bile (24.8 ± 3.7 min) than after saline infusion (13.1 ± 1.7 min; p < 0.05). The mean gallbladder volume tended to increase in the hours following bile infusion, but to decrease after saline infusion (p = 0.06). Plasma motilin increased after bile and saline infusion in an almost identical way. Conclusion: This study provides no clear evidence for a role of intraduodenal artificial bile (i.e. its main constituents) in the regulation of migrating motor complex cycling or feedback inhibition of inter-digestive gallbladder emptying.
Journal Section:
Original Paper: Motility
References
1.
Kellow JE, Borody TJ, Phillips SF, Tucker RL, Haddad AC: Human interdigestive motility: Variations in patterns from esophagus to colon. Gastroenterology 1986;91:386–395.
[PubMed]
2.
Stolk MFJ, van Erpecum KJ, Smout AJPM, Akkermans LMA, Jansen JBMJ, Lamers CBHW, Peeters TL, van Berge Henegouwen GP: Motor cycles with phase III in antrum are associated with high motilin levels and prolonged gallbladder emptying. Am J Physiol 1993;264:G596-G600.
[PubMed]
3.
Bormans V, Peeters TL, Janssens J, Pearce D, Vandeweerd M, Vantrappen G: In man, only activity fronts that originate in the stomach correlate with motilin peaks. Scand J Gastroenterol 1987;22:781–784.
[PubMed]
4.
Peeters TL, Vantrappen G, Janssens J: Bile acid output and the interdigestive migrating motor complex in normals and in cholecystectomy patients. Gastroenterology 1980;79:678–681.
[PubMed]
5.
Marzio L, Neri M, Capone F, Di Felice F, De Angelis C, Mezzetti A, Cuccurullo F: Gallbladder contraction and its relationship to interdigestive duodenal motor activity in normal human subjects. Dig Dis Sci 1988;33:540–544.
[PubMed]
6.
Peeters TL, Vantrappen G, Janssens J: Fasting plasma motilin levels are related to the interdigestive motility complex. Gastroenterology 1980;79:716–719.
[PubMed]
7.
You CH, Chey WY, Lee KY: Studies on plasma motilin concentration and interdigestive motility of the duodenum in humans. Gastroenterology 1980;79:62–66.
[PubMed]
8.
Takahashi I, Dodds WJ, Ammon H, Hogan WJ: Effect of intraduodenal bile on myoelectrical activity of the upper gastrointestinal tract and the sphincter of Oddi; in Roman C (ed): Gastrointestinal Motility. Lancaster, MTP Press, 1983, pp 249–256.
9.
Nilsson I, Svenberg T, Wallin B, Hedenborg G, Hellström PM: Activity fronts of migrating motor complex: Initiation by luminal bile acids in rat small intestine. J Gastrointest Motil 1991;3:84–91.
10.
Ozeki K, Sarna SK, Condon RE, Chey WY, Koch TR: Enterohepatic circulation is essential for regular cycling of duodenal migrating motor complexes in dogs. Gastroenterology 1992;103:759–767.
[PubMed]
11.
Nieuwenhuijs VB, Luiking YC, Verheem A, VanBerge Henegouwen GP, Gooszen HG, Akkermans LMA: Disrupted bile flow affects interdigestive small bowel motility in rats. Surgery 1997;122:600–608.
[PubMed]
12.
Plourde V, Trudel L, Poitras P: Interdigestive intestinal motility in dogs with chronic exclusion of bile from the digestive tract. Can J Physiol Pharmacol 1987;65:2493–2496.
[PubMed]
13.
Hughes SJ, Behrns KE, Sarr MG: Chronic bile diversion does not alter canine interdigestive myoelectric activity. Dig Dis Sci 1993;38:1055–1061.
[PubMed]
14.
Qvist N, Oster Jorgensen E, Rasmussen L, Kraglund K, Pedersen SA: The relationship between gallbladder dynamics and the migrating motor complex in fasting healthy subjects. Scand J Gastroenterol 1988;23:562–566.
[PubMed]
15.
Nilsson I, Svenberg T, Hedenborg G, Lordal M, Hellstrom PM: Inhibition of the migrating motor complex by duodenal drainage in man. Neurogastroenterol Motil 1995;7:31–37.
[PubMed]
16.
Nilsson I, Svenberg T, Hellström PM, Theodorsson E, Hedenborg G, Modlin IM: Pancreaticobiliary juice releases motilin during phase I of the migrating motor complex in man. Scand J Gastroenterol 1993;28:80–84.
[PubMed]
17.
Svenberg TI, Nilsson I, Samuelson K, Welbourn RD: Studies on the causal relationship between gall-bladder emptying and motilin release in man. Acta Chir Scand 1984(suppl 520):59–61.
18.
Poitras P: Motilin; in Walsh JH, Dockray GJ (eds): Gut Peptides: Biochemistry and Physiology. New York, Raven Press, 1994, pp 261–303.
19.
Lin HC, Zhao XT, Kwok GM, Gu YG, Elashoff JD: Bile salt-dependent inhibition of gallbladder emptying. Am J Physiol 1995;269:G988-G993.
[PubMed]
20.
Thimister PW, Hopman WP, Tangerman A, Rosenbusch G, Willems HL, Jansen JB: Effect of intraduodenal bile salt on pancreaticobiliary responses to bombesin and to cholecystokinin in humans. Hepatology 1998;28:1454–1460.
[PubMed]
21.
Stolk MFJ, van Erpecum KJ, Samson M, Smout AJPM, Akkermans LMA, Peeters TL, van Berge-Henegouwen GP: Interdigestive gallbladder emptying, antroduodenal motility and motilin release in cholesterol gallstone patients; in Stolk MFJ (ed): Pathogenesis of Cholesterol Gallstones; thesis, Universiteit Utrecht, 1993, pp 65–78.
22.
Festi D, Frabboni R, Bazzoli F, Sangermano A, Ronchi M, Rossi L, Parini P, Orsini M, Primerano AMM, Mazzella G, Aldini R, Roda E: Gallbladder motility in cholesterol gallstone disease. Effect of ursodeoxycholic acid administration and gallstone dissolution. Gastroenterology 1990;99:1779–1785.
[PubMed]
23.
Heaton KW, Emmett PM, Symes CL, Braddon FEM: An explanation for gallstones in normal-weight women: Slow intestinal transit. Lancet 1993;341:8–10.
[PubMed]
24.
Perdikis G, Wilson P, Hinder R, Redmond E, Wetscher G, Neary P, Adrian T, Quigley E: Altered antroduodenal motility after cholecystectomy. Am J Surg 1994;168:609–615.
[PubMed]
25.
Fort JM, Azpiroz F, Casellas F, Andreu J, Malagelada JR: Bowel habit after cholecystectomy: Physiological changes and clinical implications. Gastroenterology 1996;111:617–622.
[PubMed]
26.
Kibe A, Dudley MA, Halpern Z, Lynn MP, Breuer AC, Holzbach RT: Factors affecting cholesterol monohydrate crystal nucleation time in model systems of supersaturated bile. J Lipid Res 1985;26:1102–1111.
[PubMed]
27.
Everson GY, Braverman DZ, Johnson ML, Kern F: A critical evaluation of real-time ultrasonography for the study of gallbladder volume and contraction. Gastroenterology 1980;79:40–46.
[PubMed]
28.
Heddle R, Dent J, Read NW, Houghton LA, Toouli J, Horowitz M, Maddern GJ, Downton J: Antropyloroduodenal motor responses to intraduodenal lipid infusion in healthy volunteers. Am J Physiol 1988;254:G671–G679.
[PubMed]
29.
Samsom M: Ambulatory antroduodenal manometry with automated data analysis; in Samsom M (ed): Disordered Motor Function of the Stomach and Small Intestine in Type I Diabetes mellitus; thesis, Universiteit Utrecht, 1995, pp 29–44.
30.
Cabral DJ, Small DM: Physical chemistry of bile; in Schultz SG (ed): The Gastrointestinal System. Bethesda, American Physiological Society, 1989, pp 621–662.
31.
Sarna S, Northcott P, Belbeck L: Mechanism of cycling of migrating myoelectric complexes: Effect of morphine. Am J Physiol 1982;242:G588–G595.
[PubMed]
32.
Rao SSC, Safadi R, Lu C, Schulze Delrieu K: Manometric responses of human duodenum during infusion of HCl, hyperosmolar saline, bile and oleic acid. Neurogastroenterol Motil 1996;8:35–43.
[PubMed]
33.
Portincasa P, Peeters TL, van Berge-Henegouwen GP, van de Meeberg P, van de Heijning BJM, van Solinge W, van der Horst FAL, Jansen JBMJ, Smout AJPM, Palasciano G, van Erpecum KJ: Acute but not chronic intraduodenal bile salt depletion by cholestyramine leads to strong gallbladder contraction, altered antroduodenal motility and high plasma motilin levels (abstract). Gastroenterology 1997;112:A807.
34.
Kajiyama Y, Irie M, Enjoji A, Ozeki K, Ura K, Kanematsu T: Role of bile acids in duodenal migrating motor complexes in dogs. Dig Dis Sci 1998;43:2278–2283.
[PubMed]
35.
Luiking YC, van der Reijden AC, van Berge Henegouwen GP, Akkermans LMA: Migrating motor complex cycle duration is determined by gastric or duodenal origin of phase III. Am J Physiol 1998;275:G1246-G1251.
[PubMed]
36.
Sailer C, Pauletzki J, Klueppelberg UG, Fischer S, Sackmann M, Paumgartner G: Acute effect of ursodeoxycholic acid on gallbladder volume in healthy subjects. Scand J Gastroenterol 1996;31:512–516.
[PubMed]
37.
Howard P, Murphy GM, Dowling RH: Effects of chenodeoxycholic (CDCA) and ursodeoxycholic (UDA) acids on gall bladder (GB) emptying (abstract). Gut 1985;26:A1124.
38.
Scott RB, Strasberg SM, El-Sharkawy TY, Diamant NE: Regulation of the fasting enterohepatic circulation of bile acids by the migrating motor complex in dogs. J Clin Invest 1983;71:644–654.
[PubMed]
39.
Riepl RL, Lehnert P, Scharl A, Hempen I, Fiedler F, Teufel J, Burhol PG: Effect of intraduodenal bile and Na-taurodeoxycholate on exocrine pancreatic secretion and on plasma levels of secretin, pancreatic polypeptide, and gastrin in man. Scand J Gastroenterol 1990;25:45–53.
[PubMed]
© 2001 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2001
You do not currently have access to this content.
